• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼眶视网膜母细胞瘤:最新进展

Orbital retinoblastoma: An update.

作者信息

Honavar Santosh G, Manjandavida Fairooz P, Reddy Vijay Anand P

机构信息

Centre for Sight, Hyderabad, Telangana, India.

Eye Cancer Services, Horus Specialty Eye Care, Bangalore, India.

出版信息

Indian J Ophthalmol. 2017 Jun;65(6):435-442. doi: 10.4103/ijo.IJO_352_15.

DOI:10.4103/ijo.IJO_352_15
PMID:28643706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5508452/
Abstract

Orbital extension is a major cause of death in children with retinoblastoma in the developing countries. Delayed detection and inappropriate management contribute to poor outcome. Conventional treatment including primary orbital exenteration or chemotherapy or radiotherapy alone result in mortality as high as 70%. The recent understanding on the role of sequential multimodal therapy with a combination of high-dose chemotherapy, followed by appropriate surgery, radiotherapy, and additional adjuvant chemotherapy has helped dramatically improve life salvage.

摘要

眼眶侵犯是发展中国家视网膜母细胞瘤患儿的主要死亡原因。检测延误和处理不当导致预后不良。传统治疗方法,包括单纯的原发性眼眶内容剜除术、化疗或放疗,死亡率高达70%。最近对序贯多模式治疗作用的认识,即采用大剂量化疗,随后进行适当的手术、放疗和额外的辅助化疗,已极大地提高了挽救生命的几率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/991e2e15701f/IJO-65-435-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/6099da648493/IJO-65-435-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/1a24b557a343/IJO-65-435-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/52a988a99bca/IJO-65-435-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/378f684ad45d/IJO-65-435-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/de03a23f0331/IJO-65-435-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/ab8fe585eed7/IJO-65-435-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/8c9d88ef6ec0/IJO-65-435-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/0b202f598477/IJO-65-435-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/e5e901eedccb/IJO-65-435-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/991e2e15701f/IJO-65-435-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/6099da648493/IJO-65-435-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/1a24b557a343/IJO-65-435-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/52a988a99bca/IJO-65-435-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/378f684ad45d/IJO-65-435-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/de03a23f0331/IJO-65-435-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/ab8fe585eed7/IJO-65-435-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/8c9d88ef6ec0/IJO-65-435-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/0b202f598477/IJO-65-435-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/e5e901eedccb/IJO-65-435-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/358b/5508452/991e2e15701f/IJO-65-435-g012.jpg

相似文献

1
Orbital retinoblastoma: An update.眼眶视网膜母细胞瘤:最新进展
Indian J Ophthalmol. 2017 Jun;65(6):435-442. doi: 10.4103/ijo.IJO_352_15.
2
Retinoblastoma.视网膜母细胞瘤。
Indian J Pediatr. 2017 Dec;84(12):937-944. doi: 10.1007/s12098-017-2395-0. Epub 2017 Jun 16.
3
Recent advances and challenges in the management of retinoblastoma.视网膜母细胞瘤治疗的最新进展与挑战
Indian J Ophthalmol. 2017 Feb;65(2):133-139. doi: 10.4103/ijo.IJO_883_16.
4
Orbital retinoblastoma: where do we go from here?
J Cancer Res Ther. 2011 Jan-Mar;7(1):11-4. doi: 10.4103/0973-1482.80429.
5
SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries.SIOP-PODC 关于发展中国家视网膜母细胞瘤分级强度治疗的建议。
Pediatr Blood Cancer. 2013 May;60(5):719-27. doi: 10.1002/pbc.24468. Epub 2013 Jan 17.
6
Retinoblastoma in Turkey: results from a tertiary care center in Ankara.土耳其视网膜母细胞瘤:安卡拉一家三级护理中心的研究结果。
J Pediatr Ophthalmol Strabismus. 2013 Sep-Oct;50(5):296-303. doi: 10.3928/01913913-20130730-02. Epub 2013 Aug 6.
7
Establishment of a formal program for retinoblastoma: Feasibility of clinical coordination across borders and impact on outcome.建立一个正式的视网膜母细胞瘤项目:跨境临床协调的可行性及其对结果的影响。
Pediatr Blood Cancer. 2019 Nov;66(11):e27959. doi: 10.1002/pbc.27959. Epub 2019 Aug 18.
8
Retinoblastoma: one world, one vision.视网膜母细胞瘤:同一个世界,同一个愿景。
Pediatrics. 2008 Sep;122(3):e763-70. doi: 10.1542/peds.2008-0518.
9
[The results of multimodal treatment in retinoblastoma].[视网膜母细胞瘤的多模式治疗结果]
Oftalmologia. 1998;45(4):46-54.
10
Retinoblastoma: What is the future?视网膜母细胞瘤:未来何去何从?
Int Ophthalmol Clin. 2019 Spring;59(2):95-99. doi: 10.1097/IIO.0000000000000267.

引用本文的文献

1
Retinoblastoma with and without Extraocular Tumor Extension: A Global Comparative Study of 3435 Patients.伴有和不伴有眼外肿瘤扩展的视网膜母细胞瘤:3435例患者的全球比较研究
Ophthalmol Sci. 2024 Oct 30;5(2):100637. doi: 10.1016/j.xops.2024.100637. eCollection 2025 Mar-Apr.
2
An Unexpected Response of Orbital Retinoblastoma to Inconsistent Systemic Chemotherapy Alone.眼眶视网膜母细胞瘤对单纯不一致的全身化疗的意外反应。
Case Rep Ophthalmol. 2024 Oct 29;15(1):769-774. doi: 10.1159/000541776. eCollection 2024 Jan-Dec.
3
Clinical and Histopathologic Predictors of Survival Among Children With Retinoblastoma From Two Tertiary Health Facilities in Uganda.

本文引用的文献

1
A proposal for an international retinoblastoma staging system.关于国际视网膜母细胞瘤分期系统的一项提议。
Pediatr Blood Cancer. 2006 Nov;47(6):801-5. doi: 10.1002/pbc.20606.
2
Clinical presentation of retinoblastoma in Eastern Nepal.尼泊尔东部视网膜母细胞瘤的临床表现
Clin Exp Ophthalmol. 2005 Aug;33(4):386-9. doi: 10.1111/j.1442-9071.2005.01010.x.
3
Management of advanced retinoblastoma.晚期视网膜母细胞瘤的管理
乌干达两家三级医疗机构中视网膜母细胞瘤患儿生存情况的临床和组织病理学预测因素
Cureus. 2023 Dec 15;15(12):e50605. doi: 10.7759/cureus.50605. eCollection 2023 Dec.
4
The Potential of Aqueous Humor Sampling in Diagnosis, Prognosis, and Treatment of Retinoblastoma.房水采样在视网膜母细胞瘤的诊断、预后和治疗中的潜力。
Invest Ophthalmol Vis Sci. 2024 Jan 2;65(1):18. doi: 10.1167/iovs.65.1.18.
5
Utility of bone marrow examination in retinoblastoma and their correlation with hematological features.在视网膜母细胞瘤中骨髓检查的效用及其与血液学特征的相关性。
J Med Life. 2023 Aug;16(8):1245-1250. doi: 10.25122/jml-2023-0156.
6
Pharmacokinetics of Orbital Topotecan After Ophthalmic Artery Chemosurgery and Intravenous Infusion in the Swine Model.眼眶内拓扑替康在猪模型中经眼动脉化疗和静脉输注后的药代动力学。
Invest Ophthalmol Vis Sci. 2023 Sep 1;64(12):3. doi: 10.1167/iovs.64.12.3.
7
Enhanced Epithelial-to-Mesenchymal Transition and Chemoresistance in Advanced Retinoblastoma Tumors Is Driven by miR-181a.miR-181a驱动晚期视网膜母细胞瘤肿瘤中上皮-间质转化增强及化疗耐药。
Cancers (Basel). 2022 Oct 19;14(20):5124. doi: 10.3390/cancers14205124.
8
Title: Clinico-pathological and survival profiles of orbito-ocular tumors in Enugu Nigeria. Is there an emerging trend?标题:尼日利亚埃努古眼眶-眼部肿瘤的临床病理及生存情况。是否存在新趋势?
Rare Tumors. 2022 Feb 23;14:20363613221079763. doi: 10.1177/20363613221079763. eCollection 2022.
9
Natural History of Untreated Retinoblastoma.未经治疗的视网膜母细胞瘤的自然病史。
Cancers (Basel). 2021 Jul 21;13(15):3646. doi: 10.3390/cancers13153646.
10
Commentary: Retinoblastoma management-Where are we and where do we go from here?评论:视网膜母细胞瘤的治疗——我们现状如何,未来何去何从?
Indian J Ophthalmol. 2020 Nov;68(11):2365-2366. doi: 10.4103/ijo.IJO_1954_20.
Ophthalmol Clin North Am. 2005 Mar;18(1):65-73, viii. doi: 10.1016/j.ohc.2004.09.001.
4
A multicentre report from the Mexican Retinoblastoma Group.墨西哥视网膜母细胞瘤研究小组的一份多中心报告。
Br J Ophthalmol. 2004 Aug;88(8):1074-7. doi: 10.1136/bjo.2003.035642.
5
Fluorine-18 fluorodeoxyglucose positron emission tomography (PET) to detect vital retinoblastoma in the eye: preliminary experience.氟-18氟脱氧葡萄糖正电子发射断层扫描(PET)用于检测眼部活跃性视网膜母细胞瘤:初步经验。
Ophthalmic Genet. 2004 Mar;25(1):31-5. doi: 10.1076/opge.25.1.31.29001.
6
Extraocular retinoblastoma: a 13-year experience.眼外视网膜母细胞瘤:13年的经验
Cancer. 2003 Sep 15;98(6):1292-8. doi: 10.1002/cncr.11647.
7
Retinoblastoma in Taiwan: survival and clinical characteristics 1978-2000.台湾视网膜母细胞瘤:1978 - 2000年的生存率及临床特征
Jpn J Ophthalmol. 2002 Sep-Oct;46(5):577-80. doi: 10.1016/s0021-5155(02)00546-4.
8
Postenucleation adjuvant therapy in high-risk retinoblastoma.高危视网膜母细胞瘤的眼球摘除术后辅助治疗
Arch Ophthalmol. 2002 Jul;120(7):923-31. doi: 10.1001/archopht.120.7.923.
9
Risk factors for metastasis in retinoblastoma.视网膜母细胞瘤转移的危险因素。
Surv Ophthalmol. 2002 Jan-Feb;47(1):1-16. doi: 10.1016/s0039-6257(01)00279-x.
10
Vitrectomy in eyes with unsuspected retinoblastoma.对未被怀疑患有视网膜母细胞瘤的眼睛进行玻璃体切除术。
Ophthalmology. 2000 Dec;107(12):2250-5. doi: 10.1016/s0161-6420(00)00427-9.